Michael Andrew Chambers Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

Michael Andrew Chambers is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 10,660 shares of SRPT, which is worth approximately $1.07 Million. The most recent transaction as insider was on Mar 10, 2025, when has been sold 2,383 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K
28.79% 3M change
28.79% 12M change
Total Value Held $1.07 Million

Michael Andrew Chambers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2025
BUY
Grant, award, or other acquisition
-
2,383 Added 18.27%
10,660 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
1,846 Added 18.24%
8,277 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
1,523 Added 19.15%
6,431 Common Stock
Sep 14 2022
BUY
Open market or private purchase
$5,970,947 $104.57 p/Share
57,100 Added 34.55%
108,178 Common Stock
Aug 19 2022
BUY
Open market or private purchase
$5,009,445 $108.5 p/Share
46,170 Added 47.48%
51,078 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
4,908 Added 50.0%
4,908 Common Stock
MAC

Michael Andrew Chambers

Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT